IDYA vs NKE · rev $15.4M vs P/E 35, rev $46.40B
Ideaya Biosciences Inc (IDYA) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
Latest reported IDYA revenue for 2026-06-30 was $15.4M. Net income was -$211.0M. IDYA currently screens at market cap $2.96B.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. Revenue was up 0.2% from 2025-05-31 to 2026-05-31. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
IDYA currently screens at market cap $2.96B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the IDYA and NKE stock pages for the full models.
Not investment advice.